- Home
- KYMR vs WSBC Comparison
KYMR vs WSBC Comparison
Compare KYMR & WSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- WSBC
- Stock Information
- Founded
- KYMR 2015
- WSBC 1870
- Country
- KYMR United States
- WSBC United States
- Employees
- KYMR N/A
- WSBC N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- WSBC Major Banks
- Sector
- KYMR Health Care
- WSBC Finance
- Exchange
- KYMR Nasdaq
- WSBC Nasdaq
- Market Cap
- KYMR 3.1B
- WSBC 2.6B
- IPO Year
- KYMR 2020
- WSBC N/A
- Fundamental
- Price
- KYMR $44.91
- WSBC $32.47
- Analyst Decision
- KYMR Strong Buy
- WSBC Buy
- Analyst Count
- KYMR 16
- WSBC 6
- Target Price
- KYMR $58.94
- WSBC $38.50
- AVG Volume (30 Days)
- KYMR 875.7K
- WSBC 539.7K
- Earning Date
- KYMR 08-06-2025
- WSBC 07-29-2025
- Dividend Yield
- KYMR N/A
- WSBC 4.54%
- EPS Growth
- KYMR N/A
- WSBC N/A
- EPS
- KYMR N/A
- WSBC 1.44
- Revenue
- KYMR $58,885,000.00
- WSBC $569,805,000.00
- Revenue This Year
- KYMR $58.26
- WSBC $42.65
- Revenue Next Year
- KYMR N/A
- WSBC $12.50
- P/E Ratio
- KYMR N/A
- WSBC $22.57
- Revenue Growth
- KYMR N/A
- WSBC N/A
- 52 Week Low
- KYMR $19.45
- WSBC $26.42
- 52 Week High
- KYMR $53.27
- WSBC $37.36
- Technical
- Relative Strength Index (RSI)
- KYMR 56.82
- WSBC 60.50
- Support Level
- KYMR $43.56
- WSBC $32.88
- Resistance Level
- KYMR $45.83
- WSBC $33.42
- Average True Range (ATR)
- KYMR 1.77
- WSBC 0.60
- MACD
- KYMR -0.49
- WSBC 0.08
- Stochastic Oscillator
- KYMR 51.65
- WSBC 72.01
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.